Client: European Supplement and Medical Device Principal
A European manufacturer of supplements and medical devices came to Product Registration Indonesia while trying to fulfill a multi-million dollar contract with a major Indonesian pharmaceutical company. The deal depended on getting a supplement product properly registered with BPOM. When that registration hit a wall, the entire contract was suddenly at risk.
The Challenge: Denied Registration and Contract Risk
The client’s existing Indonesian partner reported that BPOM had denied the supplement registration due to unsubstantiated claims. For a company relying on this registration to deliver against a signed contract, the denial was more than a paperwork setback. It threatened the commercial relationship itself.
Making matters worse, the structure of the existing regulatory arrangement created a lock-in risk. The European Principal did not have direct control over its own registration and could not simply transfer it or step in to fix the issue. The partner’s regulatory setup left the client dependent on a third party to resolve a problem it did not fully control.
The Solution: Regulatory Clarity and Strategic License Holding
Product Registration Indonesia began with a detailed review of the product’s claims and clinical documentation, rather than assuming the denial reflected a genuine compliance failure.
The review found that the core issue was not the claims themselves. It was a miscommunication and a language barrier. The partner’s regulatory team had mistaken the client’s marketing materials for the formal claims submitted to BPOM, leading to a rejection that did not accurately reflect the actual regulatory dossier.
This distinction mattered. A true claims violation would have required reformulation or a lengthy correction process. A communication gap between marketing and regulatory documentation could be resolved with the right structure and oversight.
The Result: Direct Control Through License Holding
To resolve the lock-in risk and give the client a direct path forward, Product Registration Indonesia stepped in as the official License Holder, known in Indonesia as the MA Holder, for the product.
This shift gave the European Principal direct oversight of its own registration process for the first time. It also meant the client was no longer tied to the legacy BPOM account held by its original partner, removing the structural dependency that had put the contract at risk in the first place.
Why does this matter for Foreign Companies Entering Indonesia?
This case illustrates a risk that many foreign manufacturers do not anticipate until they encounter it directly. A local partner’s regulatory account is not the same as direct market access. When a company does not hold its own license, it can lose control over its own product registration exactly when clarity and speed matter most.
Product Registration Indonesia provides the local regulatory intelligence and strategic operational control that foreign manufacturers need for long-term success in the Indonesian market. Acting as an independent License Holder gives companies direct visibility into their compliance status, rather than relying entirely on a third party’s internal processes.
Note: This case study has been anonymized at the client’s request. Product and company names have been withheld, and details are presented as reported to protect client confidentiality.
Considering entering the Indonesian market, or concerned about the structure of your current regulatory partnership? Book a free 30-minute consultation with our team to review your options.
